78 related articles for article (PubMed ID: 2493337)
1. Investigations of multistage carcinogenesis: applications of in vitro-in vivo studies.
O'Connell JF; Miller DR; Morris RJ; Patskan GP; Viaje AV; Tacker K; Slaga TJ
Carcinog Compr Surv; 1989; 11():339-48. PubMed ID: 2493337
[No Abstract] [Full Text] [Related]
2. Two-stage (initiation-promotion) carcinogenesis in vivo and in vitro.
Chouroulinkov I; Lasne C
Bull Cancer; 1978; 65(3):255-64. PubMed ID: 102382
[TBL] [Abstract][Full Text] [Related]
3. The study of tumor promotion in a cell culture model for mouse skin--a tissue that exhibits multistage carcinogenesis in vivo.
Yuspa SH; Hennings H; Kulesz-Martin M; Lichti U
Carcinog Compr Surv; 1982; 7():217-30. PubMed ID: 6121622
[No Abstract] [Full Text] [Related]
4. Correlation of initiating potency of skin carcinogens with potency to induce resistance to terminal differentiation in cultured mouse keratinocytes.
Kilkenny AE; Morgan D; Spangler EF; Yuspa SH
Cancer Res; 1985 May; 45(5):2219-25. PubMed ID: 3921239
[TBL] [Abstract][Full Text] [Related]
5. Stages of tumour promotion in skin.
Marks F; Fürstenberger G
IARC Sci Publ; 1984; (56):13-22. PubMed ID: 6443102
[No Abstract] [Full Text] [Related]
6. Zapotin prevents mouse skin tumorigenesis during the stages of initiation and promotion.
Cuendet M; Oteham CP; Maiti A; Craig BA; Cushman M; Moon RC; Pezzuto JM
Anticancer Res; 2008; 28(6A):3705-9. PubMed ID: 19189653
[TBL] [Abstract][Full Text] [Related]
7. Disruption of EphA2 receptor tyrosine kinase leads to increased susceptibility to carcinogenesis in mouse skin.
Guo H; Miao H; Gerber L; Singh J; Denning MF; Gilliam AC; Wang B
Cancer Res; 2006 Jul; 66(14):7050-8. PubMed ID: 16849550
[TBL] [Abstract][Full Text] [Related]
8. Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation.
Suganuma M; Okabe S; Kurusu M; Iida N; Ohshima S; Saeki Y; Kishimoto T; Fujiki H
Int J Oncol; 2002 Jan; 20(1):131-6. PubMed ID: 11743653
[TBL] [Abstract][Full Text] [Related]
9. Correlation of anchorage-independent growth with tumorigenicity of chemically transformed mouse epidermal cells.
Colburn NH; Bruegge WF; Bates JR; Gray RH; Rossen JD; Kelsey WH; Shimada T
Cancer Res; 1978 Mar; 38(3):624-34. PubMed ID: 626967
[No Abstract] [Full Text] [Related]
10. Genetic alterations cooperate with v-Ha-ras to accelerate multistage carcinogenesis in TG.AC transgenic mouse skin.
Owens DM; Spalding JW; Tennant RW; Smart RC
Cancer Res; 1995 Jul; 55(14):3171-8. PubMed ID: 7606738
[TBL] [Abstract][Full Text] [Related]
11. Forced expression of a constitutively active form of Stat3 in mouse epidermis enhances malignant progression of skin tumors induced by two-stage carcinogenesis.
Chan KS; Sano S; Kataoka K; Abel E; Carbajal S; Beltran L; Clifford J; Peavey M; Shen J; Digiovanni J
Oncogene; 2008 Feb; 27(8):1087-94. PubMed ID: 17700521
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenesis in human skin grafted to SCID mice.
Soballe PW; Montone KT; Satyamoorthy K; Nesbit M; Herlyn M
Cancer Res; 1996 Feb; 56(4):757-64. PubMed ID: 8631010
[TBL] [Abstract][Full Text] [Related]
13. Association of gene expression with sequential proliferation, differentiation and tumor formation in murine skin.
Ridd K; Zhang SD; Edwards RE; Davies R; Greaves P; Wolfreys A; Smith AG; Gant TW
Carcinogenesis; 2006 Aug; 27(8):1556-66. PubMed ID: 16537558
[TBL] [Abstract][Full Text] [Related]
14. The action of oncogenes and growth factors in tumour initiation and promotion.
Akhurst R; Bailleul B; Brown K; Ramsden M; Fee F; Balmain A
Carcinog Compr Surv; 1989; 11():243-55. PubMed ID: 2493336
[No Abstract] [Full Text] [Related]
15. [Regulation of tumor promotion by 1 alpha, 25-dihydroxyvitamin D3, an active form of vitamin D3].
Kuroki T
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):766-72. PubMed ID: 3754414
[TBL] [Abstract][Full Text] [Related]
16. Pro/antioxidant status and AP-1 transcription factor in murine skin following topical exposure to cumene hydroperoxide.
Murray AR; Kisin ER; Kommineni C; Vallyathan V; Castranova V; Shvedova AA
Carcinogenesis; 2007 Jul; 28(7):1582-8. PubMed ID: 17234724
[TBL] [Abstract][Full Text] [Related]
17. Two-stage tumor promotion in mouse skin: an alternative interpretation.
Hennings H; Yuspa SH
J Natl Cancer Inst; 1985 Apr; 74(4):735-40. PubMed ID: 3921746
[No Abstract] [Full Text] [Related]
18. Terminal differentiation-resistant epidermal cells in mice undergoing two-stage carcinogenesis.
Miller DR; Viaje A; Aldaz CM; Conti CJ; Slaga TJ
Cancer Res; 1987 Apr; 47(7):1935-40. PubMed ID: 3815381
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol sulfate, a second messenger for the eta isoform of protein kinase C, inhibits promotional phase in mouse skin carcinogenesis.
Chida K; Murakami A; Tagawa T; Ikuta T; Kuroki T
Cancer Res; 1995 Nov; 55(21):4865-9. PubMed ID: 7585521
[TBL] [Abstract][Full Text] [Related]
20. Lack of expression of the EP2 but not EP3 receptor for prostaglandin E2 results in suppression of skin tumor development.
Sung YM; He G; Fischer SM
Cancer Res; 2005 Oct; 65(20):9304-11. PubMed ID: 16230392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
